16-4-3447 Foreign Producers'/ Exporters' Questionnaire

Information collections for import injury investigations (producers, importers, purchasers, and foreign producer questionnaires and institution notices for 5-year reviews)

Foreign producer questionnaire -tissue

Tissue Paper from China, Inv. No. 731-TA-1070B (2nd Review)

OMB: 3117-0016

Document [pdf]
Download: pdf | pdf
OMB No. 3117-0016/USITC No. 16-4-3447; Expiration Date: 6/30/2017
(No response is required if currently valid OMB control number is not displayed)

FOREIGN PRODUCERS’/EXPORTERS’ QUESTIONNAIRE
CERTAIN TISSUE PAPER PRODUCTS FROM CHINA
This questionnaire must be received by the Commission by March 8, 2016
See last page for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its review of the antidumping duty order concerning certain tissue paper products (“tissue paper”) from
China (Inv. No. 731-TA-1070B (Second Review)). The information requested in the questionnaire is requested under the
authority of the Tariff Act of 1930, title VII.

Name of firm
Address
Website
Has your firm produced or exported tissue paper (as defined on next page) at any time since January 1, 2010?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Complete all parts of the questionnaire, and return the entire questionnaire to the Commission)

Return questionnaire via the Commission Drop Box by clicking on the following link:
https://dropbox.usitc.gov/oinv/. (PIN: TISSUE)
CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my
knowledge and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout this proceeding in any other import-injury proceedings or reviews
conducted by the Commission on the same or similar merchandise.
I, the undersigned, acknowledge that information submitted in response to this request for information and throughout this
investigation or other proceeding may be disclosed to and used:
(i) by the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a
related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and
operations of the Commission including under 5 U.S.C. Appendix 3; or
(ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. I understand that all contract
personnel will sign appropriate nondisclosure agreements.
Name of Authorized Official

Title of Authorized Official

Date

Phone:
Signature

Fax:

Email address

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire – tissue paper

Page 2

PART I.--GENERAL INFORMATION
Background. On March 30, 2005, the Department of Commerce issued an antidumping duty order on
imports of tissue paper from China. On June 1, 2015, the Commission instituted a review pursuant to
section 751(c) of the Tariff Act of 1930 (19 U.S.C. § 1675(c)) (the Act) to determine whether revocation
of the order would be likely to lead to continuation or recurrence of material injury to the domestic
industry within a reasonably foreseeable time. If both the Commission and Commerce make an
affirmative determination, the order will remain in place. If either the Commission or Commerce makes
a negative determination, the Department of Commerce will revoke the order. Questionnaires and
other information pertinent to this proceeding are available at
http://wwwadmin.usitc.gov/investigations/701731/2015/certain_tissue_paper_products_china/second
_review_full.htm
Tissue paper products covered by the Order are cut-to-length sheets of tissue paper having a basis
weight not exceeding 29 grams per square meter. Tissue paper products subject to this order may or
may not be bleached, dye-colored, surface-colored, glazed, surface decorated or printed, sequined,
crinkled, embossed, and/or die cut. The tissue paper subject to this order is in the form of cut-to-length
sheets of tissue paper with a width equal to or greater than one-half (0.5) inch. Subject tissue paper may
be flat or folded, and may be packaged by banding or wrapping with paper or film, by placing in plastic
or film bags, and/or by placing in boxes for distribution and use by the ultimate consumer. Packages of
tissue paper subject to this order may consist solely of tissue paper of one color and/or style, or may
contain multiple colors and/or styles.
The merchandise subject to this order does not have specific classification numbers assigned to them
under the Harmonized Tariff Schedule of the United States (HTSUS). Subject merchandise may be under
one or more of several different subheadings, including: 4802.30, 4802.54, 4802.61, 4802.62, 4802.69,
4804.31.1000, 4804.31.2000, 4804.31.4020, 4804.31.4040, 4804.31.6000, 4804.39, 4805.91.1090,
4805.91.5000, 4805.91.7000, 4806.40, 4808.30, 4808.90, 4811.90, 4823.90, 4802.50.00, 4802.90.00,
4805.91.90, 9505.90.40. The tariff classifications are provided for convenience and customs purposes;
however, the written description of the scope of this order is dispositive.1
Excluded from the scope of this order are the following tissue paper products: (1) tissue paper products
that are coated in wax, paraffin, or polymers, of a kind used in floral and food service applications; (2)
tissue paper products that have been perforated, embossed, or die-cut to the shape of a toilet seat, i.e.,
disposable sanitary covers for toilet seats; and (3) toilet or facial tissue stock towel or napkin stock,
paper of a kind used for household or sanitary purposes, cellulose wadding, and webs of cellulose fibers
(HTSUS 4803.00.20.00 and 4803.00.40.00).
Subject tissue paper includes both bulk and consumer tissue paper products defined as follow:
Bulk tissue paper is not resold, but is used to wrap or package the purchaser's customers' purchases, as
dunnage, filler, interleaving, etc., and is incidental to the purchase of another item. Bulk tissue is
generally sold by ream (480-500 sheets) but may also be sold in half-ream or multiple-ream quantities or
by weight. It is generally sold flat or quire-folded packaged in sealed polybags and/or corrugated boxes.
Bulk tissue paper is generally plain white or solid color but may be printed with various designs.

1

On January 30, 2007, at the direction of CBP, the Department added the following HTSUS classifications to the
AD/CVD module for tissue paper: 4802.54.3100, 4802.54.6100, and 4823.90.6700. However, we note that the six
digit classifications for these numbers were already listed in the scope.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 3

Consumer tissue paper is sold to purchasers in packaged form and ready for resale to their customers,
the final end users. Consumer tissue is usually sold folded (tissue folds) in various formats and sheet
counts (5-400 sheets). Consumer tissue paper is generally plain white or solid color but may be printed
with various designs and may also include specialty tissue paper such as handmade, die-cut, hotstamped, or spot-glitter tissue paper. Club packs are consumer tissue that are sold either flat or folded
usually in quantities of 100-400 sheets.
Reporting of information.-- If information is not readily available from your records, provide carefully
prepared estimates. If your firm is completing more than one questionnaire (i.e., a producer, importer,
purchaser and/or foreign producer questionnaire), you need not respond to duplicated questions.
Confidentiality.--The commercial and financial data furnished in response to this questionnaire that
reveal the individual operations of your firm will be treated as confidential by the Commission to the
extent that such data are not otherwise available to the public and will not be disclosed except as may
be required by law (see 19 U.S.C. § 1677f). Such confidential information will not be published in a
manner that will reveal the individual operations of your firm; however, general characterizations of
numerical business proprietary information (such as discussion of trends) will be treated as confidential
business information only at the request of the submitter for good cause shown.
Verification.--The information submitted in this questionnaire is subject to audit and verification by the
Commission. To facilitate possible verification of data, please keep all files, worksheets, and supporting
documents used in the preparation of the questionnaire response. Please also retain a copy of the final
document that you submit.
Release of information.--The information provided by your firm in response to this questionnaire, as
well as any other business proprietary information submitted by your firm to the Commission in
connection with this proceeding, may become subject to, and released under, the administrative
protective order provisions of the Tariff Act of 1930 (19 U.S.C. § 1677f) and section 207.7 of the
Commission’s Rules of Practice and Procedure (19 CFR § 207.7). This means that certain lawyers and
other authorized individuals may temporarily be given access to the information for use in connection
with this proceeding or other import-injury proceedings conducted by the Commission on the same or
similar merchandise; those individuals would be subject to severe penalties if the information were
divulged to unauthorized individuals.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
I-1.

Page 4

OMB statistics.--Please report below the actual number of hours required and the cost to your
firm of completing this questionnaire.
Hours

Dollars

The questions in this questionnaire have been reviewed with market participants to ensure that
issues of concern are adequately addressed and that data requests are sufficient, meaningful,
and as limited as possible. Public reporting burden for this questionnaire is estimated to average
30 hours per response, including the time for reviewing instructions, gathering data, and
completing and reviewing the questionnaire.
We welcome comments regarding the accuracy of this burden estimate, suggestions for
reducing the burden, and any suggestions for improving this questionnaire. Please attach such
comments to your response or send to the Office of Investigations, USITC, 500 E St. SW,
Washington, DC 20436.
I-2.

Establishments covered.-- Provide the name and address of establishment(s) covered by this
questionnaire. If your firm is publicly traded, please specify the stock exchange and trading
symbol.
“Establishment”-- Each facility of a firm in China involved in the production or export of tissue
paper, including auxiliary facilities operated in conjunction with (whether or not physically
separate from) such facilities. Firms operating more than one establishment in China should
combine the data for all establishments into a single report.

I-3.

U.S. importers.--Please provide the names, contacts, email addresses, and telephone numbers
of the FIVE largest U.S. importers of your firm’s tissue paper in 2015.

No.

1
2
3
4
5

Importer’s name

Contact person

Email address

Share of
Area code
your firm’s
and
2015 U.S.
telephone
exports
number
(%)

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
I-4.

U.S. production.--Does your firm or any related firm produce, have the capability to produce, or
have any plans to produce tissue paper in the United States or other countries?
No

I-5.

Yes--Please name the firm(s) and country(ies) below and, if U.S. producer(s),
ensure that they complete the Commission’s producer questionnaire.

U.S. importation.--Does your firm or any related firm import or have any plans to import tissue
paper into the United States?
No

I-6.

Page 5

Yes--Please name the firm(s) below and ensure that they complete the
Commission’s importer questionnaire.

Business plan.--In Parts II and III of this questionnaire we request a copy of your company’s
business plan. Does your company or any related firm have a business plan or any internal
documents that describe, discuss, or analyze expected future market conditions for tissue
paper?
No

Yes--Please provide the requested documents. If you are not providing the
requested documents, please explain why not.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 6

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Justin Enck (202-205-3363,
Justin.enck@usitc.gov). Supply all data requested on a calendar-year basis.
II-1.

Contact information.--Please identify the responsible individual and the manner by which
Commission staff may contact that individual regarding the confidential information submitted
in part II.
Name
Title
Email
Telephone
Fax

II-2.

Changes in operations.--Please indicate whether your firm has experienced any of the following
changes in relation to the production of bulk and/or consumer tissue paper (specify as
appropriate) since January 1, 2010.
Check as many as appropriate.
Plant openings
Plant closings
Relocations
Expansions
Acquisitions
Consolidations
Prolonged shutdowns or
production curtailments
Revised labor agreements
Other (e.g., technology)

Please describe.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-3.

Anticipated changes in operations.--Does your firm anticipate any changes in the character of
its operations or organization (as noted above) relating to the production of tissue paper in the
future?
No

II-4.

Page 7

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce bulk and/or consumer tissue paper (specify as
appropriate) (in 1,000 square meters) for 2016 and 2017.

Anticipated changes in operations in the event the order is revoked.--Would your firm
anticipate any changes in the character of its operations or organization (as noted above)
relating to the production of tissue paper in the future if the antidumping duty order on tissue
paper from China were to be revoked?
No

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation that address this
issue. Include in your response a specific projection of your firm’s
capacity to produce bulk and/or consumer tissue paper (specify as
appropriate) (in 1,000 square meters) for 2016 and 2017.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 8

II-5a. Production using same machinery.-- Please report your firm’s production of products made on
the same equipment and machinery used to produce tissue paper, and the combined production
capacity on this shared equipment and machinery.
“Overall production capacity” or “capacity” –The level of production that your
establishment(s) could reasonably have expected to attain during the specified periods for all
products manufactured in that establishment using the same manufacturing equipment.
Assume normal operating conditions (i.e., using equipment and machinery in place and ready to
operate; normal operating levels (hours per week/weeks per year) and time for downtime,
maintenance, repair, and cleanup).
“Production” --All production in your establishment(s) in China, including production consumed
internally within your firm.
Quantity (in 1,000 square meters)
Calendar year
Item

2013

2014

2015

Overall production capacity
Production of:
1
Bulk tissue paper
Consumer tissue paper

2

0

0

0

0

0

0

0

0

0

3

Other products
Total
1

Data entered for production of bulk tissue paper will populate here once reported in question II-14.
Data entered for production of consummer tissue paper will populate here once reported in question II-15.
3
Please identify these products:
.

2

II-5b.

Operating parameters.--The production capacity reported in II-5a is based on operating
per week,
weeks per year.

II-5c.

Capacity calculation.--Please describe the methodology used to calculate overall production
capacity reported in II-5a, and explain any changes in reported capacity.

II-5d.

Production constraints.--Please describe the constraint(s) that set the limit(s) on your firm’s
production capacity.

hours

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-5e.

Page 9

Product shifting.
(i).

Is your firm able to switch production (capacity) between tissue paper and other products
using the same equipment and/or labor?
No

(ii).

Yes-- (i.e., have produced other products or are able to produce other
products). Please identify other actual or potential products.

Please describe the factors that affect your firm’s ability to shift production capacity
between products (e.g., time, cost, relative price change, etc.), and the degree to which
these factors enhance or constrain such shifts.

II-6.

Share of sales.--What percentage of your firm’s total sales in its most recent fiscal year was
represented by sales of tissue paper?
• Bulk tissue paper:
percent.
• Consumer tissue paper:
percent.

II-7.

Firm's estimated share of production in country.--Please estimate the percentage of total
production of tissue paper in the country specified on the certification page accounted for by your
firm’s production in 2015.
• Bulk tissue paper:
percent.
• Consumer tissue paper:
percent.

II-8.

Firm's estimated share of country's exports.--Please estimate the percentage of total exports to
the United States of tissue paper from the country specified on the certification page accounted
for by your firm’s exports in 2015.
• Bulk tissue paper:
percent.
• Consumer tissue paper:
percent.

II-9.

Inventories in the United States.--Has your firm, since 2013, maintained any inventories of
tissue paper in the United States (not including inventories held by firms identified in question
I-3)?
“Inventories”--Finished goods inventory, not raw materials or work in progress.
No

Yes--Report the quantity of such end-of-period inventories below.
Quantity (in 1,000 square meters)
Calendar year

Item
Bulk tissue paper
Consumer tissue paper

2013

2014

2015

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-10.

Page 10

Third country trade actions.--Is the tissue paper exported by your firm subject to
antidumping/countervailing duty/safeguard findings, remedies, or proceedings?
No

Yes--List the products(s), countries affected, and the date of such
findings/remedies/proceedings.

II-11.

Other export markets.--Identify export markets (other than the United States) that your firm
has developed or where it has increased its sales of bulk and/or consumer tissue paper (specify
as appropriate) since 2010. Please identify and discuss below.

II-12.

Significance of the antidumping duty order.--Describe the significance of the existing
antidumping duty order covering imports of tissue paper from China in terms of its effect on
your firm’s production capacity, production, home market shipments, exports to the United
States and other markets, and inventories. You may wish to compare your firm’s operations
before and after the imposition of the order.

II-13.

Anticipated changes if order revoked.--Would your firm anticipate any changes in its
production capacity, production, home market shipments, exports to the United States and
other markets, or inventories relating to the production of bulk and/or consumer tissue paper
(specify as appropriate) in the future if the antidumping duty order on tissue paper from China
were to be revoked?
No

Yes–Supply details as to the time, nature, and significance of such changes
and provide underlying assumptions, along with relevant portions of
business plans or other supporting documentation for any trends or
projections you may provide.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 11

Trade data.--Report your firm’s production capacity, production, shipments, and inventories
related to the production of bulk tissue paper and consumer tissue paper in your
establishment(s) in China during the specified periods in tables II-14 and II-15.
Do not submit data by manufacturing facility if they are in the same country. If your firm has
multiple manufacturing establishments within one country, you are required to combine data
for those establishments within one foreign producer questionnaire response.
Do not submit data on multiple countries combined. The establishments reported here should
all be located in the country of the firm’s address reported on the certification page.
Multinational companies with production in multiple subject countries should submit separate
foreign producer questionnaire responses for each subject country.
“Average production capacity” or “capacity” –The level of production that your
establishment(s) could reasonably have expected to attain during the specified periods for all
products manufactured in that establishment using the same manufacturing equipment.
Assume normal operating conditions (i.e., using equipment and machinery in place and ready to
operate; normal operating levels (hours per week/weeks per year) and time for downtime,
maintenance, repair, and cleanup; and a typical or representative product mix).
“Production” --All production in your establishment(s) in China, including production consumed
internally within your firm.
“Shipments”--Shipments of products produced in your establishment(s) in China. Quantities
reported should be net of returns. Report net values (i.e., gross sales values less all
discounts, allowances, rebates, prepaid freight, and the value of returned goods) in U.S.
dollars, f.o.b. your point of shipment in China.
“Home market commercial shipments”--Shipments, other than internal consumption and
transfers to related firms, within China.
“Home market internal consumption/transfers to related firms”--Shipments made to
related firms in China, including product consumed internally by your firm.
“Export shipments”--Shipments to destinations outside China, including shipments
to related firms.
“Inventories”--Finished goods inventory, not raw materials or work-in-progress.
Note: As requested in Part I of this questionnaire, please keep all supporting documents/records
used in the preparation of the trade data, as Commission staff may contact your firm regarding
questions on the trade data. The Commission may also request that your company submit copies
of the supporting documents/records (such as production and sales schedules, inventory records,
etc.) used to compile these data.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-14.

Page 12

Trade data for bulk tissue paper.
“Bulk tissue paper” – is sold to retailers for their own use and not for resale to consumers. Bulk
tissue is generally sold by ream (480-500 sheets) but may also be sold in half-ream or multipleream quantities or by weight. It is generally sold flat or quire-folded packaged in sealed
polybags and/or corrugated boxes. Bulk tissue paper is generally plain white or solid color but
may be printed with various designs.
Quantity (in 1,000 square meters), value (in 1,000 dollars)
Calendar year
Item

2013

2014

2015

1

Average production capacity (A)
Beginning-of-period inventories (B)
Production (C)
Home market shipments:
Internal consumption/ transfers
quantity (D)
value (E)
Commercial shipments
quantity (F)
value (G)
Export shipments:
to the United States:
quantity (H)
value (I)
to the European Union:2
quantity (J)
value (K)
to Asia:3
quantity (L)
value (M)
to all other markets:4
quantity (N)
value (O)
Total exports (quantity) (P)

0

0

0

Total shipments (quantity) (Q)

0

0

0

End-of-period inventories (R)
1

The production capacity reported is based on operating
hours per week,
weeks per
year. Please describe the methodology used to calculate production capacity, and explain any changes
in reported capacity:
.
2
Identify your firm’s principal European Union export markets:
.
3
Identify your firm’s principal Asian export markets:
.
4
Identify your firm’s principal other export markets:
.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-14.

Page 13

Trade data for bulk tissue paper.—Continued.
RECONCILIATION OF SHIPMENTS, PRODUCTION, AND INVENTORY.--Generally, the data reported
for the end-of-period inventories (i.e., line R) should be equal to the beginning-of-period
inventories (i.e., line B), plus production (i.e., line C), less total shipments (i.e., lines D, F, H, J, L,
and N). Please ensure that any differences are not due to data entry errors in completing this
form, but rather actually reflect your firm’s records; and also provide any likely explanations for
any differences (e.g., theft, loss, damage, record systems issues, etc.) if they exist.
Calendar year
Item

B + C – D – F – H –J – L – N – R= should equal zero
("0") or provide an explanation.1
1

2013

2014

0

2015

0

Explanation if the calculated fields above are returning values other than zero (i.e., “0”) but are
nonetheless accurate:
.

0

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-15.

Page 14

Trade data for consumer tissue paper.
“Consumer tissue paper” -- is sold to retailers for resale to consumers. Consumer tissue is
usually sold folded (tissue folds) in various formats and sheet counts (5-400 sheets). Consumer
tissue paper is generally plain white or solid color but may be printed with various designs and
may also include specialty tissue paper such as handmade, die-cut, hot-stamped, or spot-glitter
tissue paper. Club packs are consumer tissue that are sold either flat or folded usually in
quantities of 100-400 sheets.
Quantity (in 1,000 square meters), value (in 1,000 dollars)
Calendar year
Item

2013

2014

2015

1

Average production capacity (A)
Beginning-of-period inventories (B)
Production (C)
Home market shipments:
Internal consumption/ transfers
quantity (D)
value (E)
Commercial shipments
quantity (F)
value (G)
Export shipments:
to the United States:
quantity (H)
value (I)
to the European Union:2
quantity (J)
value (K)
to Asia:3
quantity (L)
value (M)
to all other markets:4
quantity (N)
value (O)
Total exports (quantity) (P)

0

0

0

Total shipments (quantity) (Q)

0

0

0

End-of-period inventories (R)
1

The production capacity reported is based on operating
hours per week,
weeks per
year. Please describe the methodology used to calculate production capacity, and explain any changes
in reported capacity:
.
2
Identify your firm’s principal European Union export markets:
.
3
Identify your firm’s principal Asian export markets:
.
4
Identify your firm’s principal other export markets:
.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
II-15.

Page 15

Trade data for consumer tissue paper.--Continued.
RECONCILIATION OF SHIPMENTS, PRODUCTION, AND INVENTORY.--Generally, the data reported
for the end-of-period inventories (i.e., line R) should be equal to the beginning-of-period
inventories (i.e., line B), plus production (i.e., line C), less total shipments (i.e., lines D, F, H, J, L,
and N). Please ensure that any differences are not due to data entry errors in completing this
form, but rather actually reflect your firm’s records; and also provide any likely explanations for
any differences (e.g., theft, loss, damage, record systems issues, etc.) if they exist.
Calendar year
Item

2013

B + C – D – F – H –J – L – N – R= should equal zero
("0") or provide an explanation.1

2014

0

2015

0

0

1

Explanation if the calculated fields above are returning values other than zero (i.e., “0”) but are
nonetheless accurate:
.

II-16.

Export data (2010-12).-- Report the quantity and value of your firm’s exports of tissue paper to
the United States during the specified periods.
Quantity (in 1,000 square meters), value (in 1,000 dollars)
Item

2010

2011

2012

Bulk tissue paper
(Quantity)
(Value)
Quantity (in 1,000 square meters), value (in 1,000 dollars)
Item

2010

2011

2012

Consumer tissue paper
(Quantity)
(Value)

II-17.

Other explanations.--If your firm would like to further explain a response to a question in Part II
that did not provide a narrative box, please note the question number and the explanation in
the space provided below. Please also use this space to highlight any issues your firm had in
providing the data in this section, including but not limited to technical issues with the MS Word
questionnaire.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 16

PART III.--MARKET FACTORS
Further information on this part of the questionnaire can be obtained from Tana Farrington (202-2052389, Tana.Farrington@usitc.gov).
III-1.

Contact information.-- Please identify the responsible individual and how Commission staff may
contact the individual regarding the confidential information submitted in part III.
Name
Title
Email
Telephone
Fax

PLEASE NOTE THAT THE QUESTIONS IN PART III (PAGES 16-23) OF THIS QUESTIONNAIRE REFER TO
BOTH BULK AND CONSUMER TISSUE PAPER. IF THE ANSWERS TO THE QUESTIONS IN THESE SECTIONS
DIFFER BY END USE (I.E., BULK TISSUE PAPER OR CONSUMER TISSUE PAPER, DEFINED ON PAGE 2),
PLEASE IDENTIFY THE PRODUCT YOUR FIRM PRODUCES THE MOST OF IN RELATION TO YOUR TOTAL
PRODUCTION OF TISSUE PAPER.
Mostly produce bulk
tissue paper

III-2.

Mostly produce
consumer tissue paper

Produce
approximately equal
amounts of bulk and
consumer tissue paper

Contract versus spot.--Approximately what share of your firm’s sales of tissue paper to U.S.
customers in 2015 was on a (1) long-term contract basis, (2) annual contract basis, (3) shortterm contract basis, and (4) spot sales basis?

Share of your
2015 sales

Long-term
contracts
(multiple
deliveries for
more than 12
months)
%

Type of sale
Short-term
Annual
contracts
contracts
(multiple
(multiple
deliveries for
deliveries for 12
less than 12
months)
months)
%

Total
(should
sum to
100.0%)

Spot sales
(for a single
delivery)
%

%

0.0

%

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
III-3.

Page 17

Contract provisions.— Please fill out the table regarding your firm’s typical sales contracts with
U.S. customers for tissue paper (or check “not applicable” if your firm does not sell on a longterm, short-term and/or annual contract basis).

Typical sales
contract provisions

Item

Average contract
duration

No. of
days

Price renegotiation
(during contract
period)

Yes

Short-term contracts
(multiple deliveries
for less than 12
months)

Annual contracts
(multiple
deliveries for 12
months)

Long-term contracts
(multiple deliveries for
more than 12 months)

365

No
Quantity

Fixed quantity
and/or price

Price
Both
Yes

Meet or release
provision

No

Not applicable
III-4.

Lead times.— What is your firm’s share of sales from inventory and produced to order and what
is the typical lead time between a customer’s order and the date of delivery for your firm’s sales
of tissue paper?

Source

Share of 2015 sales

From inventory

%

Produced to order

%

Total (should sum to 100.0%)
III-5.

Lead time
(average
number of
days)

0.0 %

Raw materials.-- Indicate how tissue paper raw materials prices have changed since January 1,
2010, and how you expect they will change in the future.

Raw
materials
prices
Changes since
January 1,
2010
Anticipated

Fluctuate
with no
clear
Overall
No
Overall
increase change decrease trend

Explain, noting how raw material
price changes have affected your
firm’s selling prices for tissue paper.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
changes

Page 18

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper
III-6.

Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of China-produced tissue paper in the
U.S. market since January 1, 2010?
No

III-7.

Page 19

Yes

If yes, please describe.

Availability of SUBJECT import supply.-- Do you anticipate any changes in terms of the
availability of China-produced tissue paper in the U.S. market in the future?

Product

If you anticipate changes in supply, please identify
the changes, including the time period and the
impact of such changes on shipment volumes and
No
Increase change Decrease prices.

Bulk
Consumer
III-8.

Product shifting.--Describe how easily your firm can shift its sales of tissue paper between the
U.S. market and alternative country markets. In your discussion, please describe any contracts,
other sales arrangements, or other constraints (including any third-country trade barriers such
as tariffs, quotas, or other non-tariff barriers) that would prevent or retard your firm from
shifting tissue paper between the U.S. and alternative country markets within a 12-month
period.

III-9.

Product range.--Is the product range, product mix, or marketing of tissue paper in your firm’s
home market different from that of tissue paper for export to the United States or to thirdcountry markets?
No

Yes

If yes, please explain.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 20

III-10. Product changes.--Have there been any significant changes in the product range, product mix,
or marketing of tissue paper in your firm’s home market, for export to the United States, or for
export to third-country markets since January 1, 2010? Do you anticipate any future changes?
Changes in
product range,
product mix, or
marketing
No Yes

Explain

Changes since
January 1, 2010
Anticipated
changes
III-11. Substitutes. -(a)

Can other products be substituted for tissue paper?
No

Substitute

Yes--Please fill out the table.

End use in which this
substitute is used

Have changes in the price of this substitute
affected the price for tissue paper?
No Yes

Explanation

1.
2.
3.
(b)

Have there been any changes in the number or types of products that can be
substituted for tissue paper since January 1, 2010? Do you anticipate any future
changes?
Changes in
substitutes

Changes since
January 1, 2010
Anticipated
changes

No Yes

Explain

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 21

III-12. Interchangeability.--Is the tissue paper produced by your firm and sold in its home market
interchangeable (i.e., can be used in the same applications) with your firm’s tissue paper sold to
the United States and/or to third-country markets?
Yes

No

If no, identify the market(s) and any differences in the products.

III-13. End uses.—
(a)

Describe the end uses of the tissue paper that your firm manufactures and sell to your
firm’s home market. If these end uses differ from those of the tissue paper your firm
sells to the U.S. market or to third-country markets, explain.

(b)

Have there been any changes in the end uses of tissue paper since January 1, 2010? Do
you anticipate any future changes?

Changes in end
uses
Changes since
January 1, 2010
Anticipated
changes

No

Yes

Explain

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 22

III-14. Demand trends.—
(a) Indicate how demand in the following markets for bulk tissue paper has changed since January
1, 2010, and how you anticipate demand will change in the future. Explain any trends and
describe the principal factors that have affected, and that you anticipate will affect, these
changes in demand.

Your firm’s Overall
market
increase

Fluctuate
No
Overall
with no
change decrease clear trend
Demand since January 1, 2010

Home
market
United
States
Other
markets
Anticipated future demand
Home
market
United
States
Other
markets

Explanation and factors

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 23

III-14. Demand trends (continued).—
(b) Indicate how demand in the following markets for consumer tissue paper has changed since
January 1, 2010, and how you anticipate demand will change in the future. Explain any trends
and describe the principal factors that have affected, and that you anticipate will affect, these
changes in demand.

Your firm’s Overall
market
increase

Fluctuate
No
Overall
with no
change decrease clear trend

Explanation and factors

Demand since January 1, 2010
Home
market
United
States
Other
markets
Anticipated future demand
Home
market
United
States
Other
markets
III-15. Price differences.--Please compare market prices of tissue paper in your firm’s home market,
the United States, and third-country markets.

III-16. International transportation.—
(a)

Who typically arranges international transportation for your firm’s exports?
Exporter

(b)

Importer

If your firm typically arranges international transportation:
For 2015, report or estimate the average cost to ship typical
volumes of tissue paper from the China to the United States

dollars per 1,000
square meters

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 24

III-17. Description of home market.--Describe briefly your firm’s home market for tissue paper,
including the number of, and competition between, producers.

III-18. Import competition.--Does your firm face competition from imports of tissue paper in your
firm’s home market?
No

Yes

If yes, please identify the country sources of these imports.

III-19. Market studies.--Please provide as a separate attachment to this request any studies, surveys,
etc. that you are aware of that quantify and/or otherwise discuss tissue paper supply (including
production capacity and capacity utilization) and demand in (1) the United States, (2) each of
the other major producing/consuming countries, including China, and (3) the world as a whole.
Of particular interest is such data from 2010 to the present and forecasts for the future.
III-20. Further explanation of bulk vs. consumer tissue paper.-- If any of your answers above differed
between bulk and consumer tissue paper, please provide any further explanations below.

III-21. Other explanations.--If your firm would like to further explain a response to a question in Part III
that did not provide a narrative response box, please note the question number and the
explanation in the space provided below. Please also use this space to highlight any issues your
firm had in providing the data in this section, including but not limited to technical issues with
the MS Word questionnaire.

Business Proprietary
Foreign Producers’/Exporters’ Questionnaire - Tissue Paper

Page 25

HOW TO FILE YOUR QUESTIONNAIRE RESPONSE
This questionnaire is available as a “fillable” form in MS Word format on the
Commission’s website at:
http://wwwadmin.usitc.gov/investigations/701731/2015/certain_tissue_paper_product
s_china/second_review_full.htm
Please do not attempt to modify the format or permissions of the questionnaire
document. Please submit the completed questionnaire using one of the methods noted
below. If your firm is unable to complete the MS Word questionnaire or cannot use one
of the electronic methods of submission, please contact the Commission for further
instructions.
• Upload via Secure Drop Box.—Upload the MS Word questionnaire along with a scanned copy of the
signed certification page (page 1) through the Commission’s secure upload facility:
Web address: https://dropbox.usitc.gov/oinv/

Pin: TISSUE

• E-mail.—E-mail the MS Word questionnaire to Justin.enck@usitc.gov; include a scanned copy of the
signed certification page (page 1). Submitters are strongly encouraged to encrypt nonpublic documents
that are electronically transmitted to the Commission to protect your sensitive information from
unauthorized disclosure. The USITC secure drop-box system and the Electronic Document Information
System (EDIS) use Federal Information Processing Standards (FIPS) 140-2 cryptographic algorithms to
encrypt data in transit. Submitting your nonpublic documents by a means that does not use these
encryption algorithms (such as by email) may subject your firm’s nonpublic information to unauthorized
disclosure during transmission. If you choose a non-encrypted method of electronic transmission, the
Commission warns you that the risk of such possible unauthorized disclosure is assumed by you and not
by the Commission.
If your firm did not produce or export this product, please fill out page 1, print, sign, and submit a
scanned copy to the Commission.
Parties to this proceeding.—If your firm is a party to this proceeding, it is required to serve a copy of the
completed questionnaire on parties to the proceeding that are subject to administrative protective
order (see 19 CFR § 207.7). A list of such parties may be obtained from the Commission’s Secretary (202205-1803). A certificate of service must accompany the completed questionnaire you submit (see 19 CFR
§ 207.7). Service of the questionnaire must be made in paper form.


File Typeapplication/pdf
File TitleUSITCQUESTIONNAIRE
AuthorFarrington, Tana
File Modified2016-02-09
File Created2016-02-09

© 2024 OMB.report | Privacy Policy